This inventor holds 1 USPTO granted patent. Top assignee: S O 'Pharmachim'. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Alexander P Monov
Introduction
Alexander P Monov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative antihypoxic drug. His work focuses on developing treatments that enhance the body's resilience against hypoxic conditions.
Latest Patents
Monov holds a patent for an antihypoxic drug and method of its application. This drug, which combines piracetam and orotic acid or their pharmaceutically tolerable salts, is designed to provide verebroprotective and hepatoprotective effects. The formulation is administered in varying daily doses, ranging from 0.150 to 50 g, depending on the severity of the condition being treated. Clinical data supports the synergistic effect of this combination, demonstrating its efficacy in treating both acute and chronic diseases, as well as exogenic intoxications.
Career Highlights
Monov is associated with S O Pharmachim, where he continues to develop and refine his pharmaceutical innovations. His dedication to improving medical treatments has positioned him as a key figure in the industry. His work not only addresses immediate health concerns but also contributes to the broader understanding of drug interactions and therapeutic applications.
Collaborations
Monov has collaborated with several professionals in his field, including Ani I Genova and Milka P Nikolova. These partnerships have facilitated the advancement of his research and the successful development of his patented drug.
Conclusion
Alexander P Monov's contributions to the field of pharmaceuticals, particularly through his antihypoxic drug, highlight his innovative spirit and commitment to improving health outcomes. His work exemplifies the impact of dedicated research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile